Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Interleukin-based therapy for Pulmonary Hypertension: IL-1β inhibits the development of pulmonary hypertension via down regulation of its target genes, 21/January/2015, 9.27 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that IL-1β, by increasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “ IL-1β or its activators” may be used to treat pulmonary hypertension.
Amount: $ 500
Undisclosed information: How IL-1β inhibits the development of pulmonary hypertension
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
